Trial
|
Expression level
|
Noise stdev
|
Time scale (days)
|
Penetrance
|
Mean onset
|
---|
1b
|
50%
|
0.2
|
2
|
0.31
|
2.1/5.9
|
2
|
50%
|
0.5
|
2
|
0.94
|
22.1/20.4
|
3
|
50%
|
1.0
|
2
|
1.0
|
12.5/10.6
|
4
|
50%
|
0.2
|
5
|
0.91
|
21.9/21.8
|
5c
|
52.5%
|
0.5
|
2
|
0.20
|
6.1/18.7
|
6
|
52.5%
|
1.0
|
2
|
0.95
|
17.8/15.9
|
7d
|
52.5%
|
0.5
|
5
|
0.54
|
7.5/13.0
|
8
|
52.5%
|
1.0
|
5
|
1.0
|
22.0/18.5
|
9
|
55%
|
0.5
|
2
|
0.0
|
--
|
10
|
55%
|
0.5
|
5
|
0.0
|
--
|
11e
|
55%
|
1.0
|
2
|
0.34
|
8.8/19.2
|
12
|
55%
|
1.0
|
5
|
1.0
|
2.7/0.1
|
13f
|
60%
|
1.0
|
5
|
0.0
|
--
|
- Sensitivity of feedback loop 2.a to changes in stochasticity is illustrated here using 100-trial simulations. Expression level is such that 50% is at the critical level: slightly lower expression, with no noise, allows disease to deterministically occur all the time. 100 simulations for each set of conditions were run to compute a penetrance value. When no noise is present, the system is deterministic and no disease occurs as long as the base expression level is 50% or higher. When expression is 60% or higher, no disease occurs even with the highest level of random variation used in this study.